CN114568557A - 一种参多糖甜婺金花红茶及其制备方法 - Google Patents
一种参多糖甜婺金花红茶及其制备方法 Download PDFInfo
- Publication number
- CN114568557A CN114568557A CN202210131791.6A CN202210131791A CN114568557A CN 114568557 A CN114568557 A CN 114568557A CN 202210131791 A CN202210131791 A CN 202210131791A CN 114568557 A CN114568557 A CN 114568557A
- Authority
- CN
- China
- Prior art keywords
- powder
- sweet
- black tea
- golden flower
- polysaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 113
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 113
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 113
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 87
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 82
- 235000006468 Thea sinensis Nutrition 0.000 title claims abstract description 82
- 235000020279 black tea Nutrition 0.000 title claims abstract description 82
- 241000208340 Araliaceae Species 0.000 title claims abstract description 58
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 58
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 58
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 58
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 100
- 238000002156 mixing Methods 0.000 claims abstract description 43
- 239000002994 raw material Substances 0.000 claims abstract description 32
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 29
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 29
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 235000005911 diet Nutrition 0.000 claims abstract description 26
- 241000233866 Fungi Species 0.000 claims abstract description 24
- 239000002131 composite material Substances 0.000 claims abstract description 23
- 230000000378 dietary effect Effects 0.000 claims abstract description 23
- 229920002101 Chitin Polymers 0.000 claims abstract description 15
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 15
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 15
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 15
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 15
- 241001122767 Theaceae Species 0.000 claims description 50
- 235000013616 tea Nutrition 0.000 claims description 46
- 238000001035 drying Methods 0.000 claims description 25
- 238000005303 weighing Methods 0.000 claims description 20
- 238000012545 processing Methods 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 16
- 235000019225 fermented tea Nutrition 0.000 claims description 14
- 238000007791 dehumidification Methods 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 230000002829 reductive effect Effects 0.000 claims description 10
- 238000007873 sieving Methods 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 241001365741 Lithocarpus litseifolius Species 0.000 claims description 9
- 238000000855 fermentation Methods 0.000 claims description 9
- 230000004151 fermentation Effects 0.000 claims description 9
- 241000123889 Rubus chingii Species 0.000 claims description 7
- 244000228451 Stevia rebaudiana Species 0.000 claims description 7
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 5
- 238000010025 steaming Methods 0.000 claims description 5
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 238000005096 rolling process Methods 0.000 claims description 4
- 238000010563 solid-state fermentation Methods 0.000 claims description 4
- 240000000588 Hericium erinaceus Species 0.000 claims description 3
- 235000007328 Hericium erinaceus Nutrition 0.000 claims description 3
- 240000000599 Lentinula edodes Species 0.000 claims description 3
- 244000252132 Pleurotus eryngii Species 0.000 claims description 3
- 235000001681 Pleurotus eryngii Nutrition 0.000 claims description 3
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims 1
- 235000001715 Lentinula edodes Nutrition 0.000 claims 1
- 240000003553 Leptospermum scoparium Species 0.000 claims 1
- 235000015459 Lycium barbarum Nutrition 0.000 claims 1
- 238000007605 air drying Methods 0.000 claims 1
- 230000009849 deactivation Effects 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 15
- 230000006870 function Effects 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 14
- 235000016709 nutrition Nutrition 0.000 abstract description 14
- 230000004060 metabolic process Effects 0.000 abstract description 13
- 230000035764 nutrition Effects 0.000 abstract description 13
- 230000001737 promoting effect Effects 0.000 abstract description 11
- 230000001105 regulatory effect Effects 0.000 abstract description 11
- 210000003734 kidney Anatomy 0.000 abstract description 8
- 210000004185 liver Anatomy 0.000 abstract description 8
- 208000017667 Chronic Disease Diseases 0.000 abstract description 7
- 210000004072 lung Anatomy 0.000 abstract description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 230000002490 cerebral effect Effects 0.000 abstract description 5
- 210000002216 heart Anatomy 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000000474 nursing effect Effects 0.000 abstract description 4
- 238000001784 detoxification Methods 0.000 abstract description 3
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract description 2
- 230000007815 allergy Effects 0.000 abstract description 2
- 210000001124 body fluid Anatomy 0.000 abstract description 2
- 239000010839 body fluid Substances 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 241000114343 Lonicera caprifolium Species 0.000 abstract 1
- 239000000047 product Substances 0.000 description 27
- 240000001548 Camellia japonica Species 0.000 description 18
- 235000018597 common camellia Nutrition 0.000 description 17
- 239000003814 drug Substances 0.000 description 17
- 230000000694 effects Effects 0.000 description 13
- 238000011160 research Methods 0.000 description 13
- 230000036541 health Effects 0.000 description 11
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 230000036039 immunity Effects 0.000 description 7
- 241001205401 Aspergillus cristatus Species 0.000 description 6
- 235000013325 dietary fiber Nutrition 0.000 description 6
- 230000002124 endocrine Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 description 5
- 229940126902 Phlorizin Drugs 0.000 description 5
- 235000010980 cellulose Nutrition 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 230000036737 immune function Effects 0.000 description 5
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 description 5
- IOUVKUPGCMBWBT-GHRYLNIYSA-N phlorizin Chemical compound O[C@@H]1[C@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-GHRYLNIYSA-N 0.000 description 5
- 235000019139 phlorizin Nutrition 0.000 description 5
- RHCSKNNOAZULRK-APZFVMQVSA-N 2,2-dideuterio-2-(3,4,5-trimethoxyphenyl)ethanamine Chemical compound NCC([2H])([2H])C1=CC(OC)=C(OC)C(OC)=C1 RHCSKNNOAZULRK-APZFVMQVSA-N 0.000 description 4
- 241000219780 Pueraria Species 0.000 description 4
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 4
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 4
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 241001618264 Rubus coreanus Species 0.000 description 3
- 240000007651 Rubus glaucus Species 0.000 description 3
- 235000011034 Rubus glaucus Nutrition 0.000 description 3
- 235000009122 Rubus idaeus Nutrition 0.000 description 3
- YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000003266 anti-allergic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 208000017701 Endocrine disease Diseases 0.000 description 2
- 208000009849 Female Genital Neoplasms Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010039424 Salivary hypersecretion Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003579 anti-obesity Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000008512 biological response Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000030172 endocrine system disease Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 208000026451 salivation Diseases 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000228427 Eurotiales Species 0.000 description 1
- 241001136487 Eurotium Species 0.000 description 1
- 239000001689 FEMA 4674 Substances 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000036110 Neuroinflammatory disease Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000731396 Pueraria montana var. thomsonii Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930182647 Trilobatin Natural products 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 210000003486 adipose tissue brown Anatomy 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000000798 anti-retroviral effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 230000003293 cardioprotective effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000007278 cognition impairment Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- -1 i.e. Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000003818 metabolic dysfunction Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003959 neuroinflammation Effects 0.000 description 1
- 230000004112 neuroprotection Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000021062 nutrient metabolism Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000011206 ternary composite Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000035924 thermogenesis Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- GSTCPEBQYSOEHV-QNDFHXLGSA-N trilobatin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GSTCPEBQYSOEHV-QNDFHXLGSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000009137 wuling Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/90—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in food processing or handling, e.g. food conservation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Food Science & Technology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Polymers & Plastics (AREA)
Abstract
本发明涉及一种参多糖甜婺金花红茶及其制备方法，该金花红茶由以下重量百分数的各原料组成：人参多糖粉10‑40％；葛根膳食纤维素粉5‑25％；食用菌多糖粉0.5‑5％；淼甜婺金花红茶粉40‑70％；脱乙酰基甲壳素粉2‑10％；微晶纤维素粉0.5‑2.5％。其制备方法包括多糖成分混合成多糖复合粉、淼甜婺金花红茶粉碎及添加混合及微晶纤维素的添加等步骤。本发明提供的参多糖甜婺金花红茶是由各种有效成份配合而成，具备生津、清热、抗炎、抗敏，调理气血平衡，护理肺、肝、肾、心脑血管等功能，可有效增强人的免疫代谢营养，促进人体胃肠道、血液代谢排毒功能，尤其适用于对女性慢性疾病的预防、辅助医疗和康复。
Description
技术领域
本发明涉及现代生命科学、中医药学、营养学和预防医学领域；具体涉及一种具有对人体机体免疫营养供给、调理内分泌、调理气血平衡、促进综合代谢，具有护理心脑血管、肝、肺、肾等脏器功能和改善人体营养平衡、调理胃肠道并促进胃肠代谢、血液体代谢等重要特殊膳食的饮食疗作用的参多糖甜婺金花红茶及其制备方法。
背景技术
参多糖甜婺金花茶产品项目研究论证背景:社会女性人群的健康是人类社会健康的基础；由于女性生理的特殊性，当代社会女性普遍存在内分泌功能紊乱、综合代谢功能失调、免疫功能低下，女性乳腺炎、乳腺肿瘤、糖尿病、高血脂、生理性经期失调、经期失血性贫血、心脑血管硬化、失眠、胃肠道代谢紊乱、便秘、下身宫寒、妇科肿瘤等等女性慢性疾病较普遍存在。上述慢性疾病已严重威胁、损害女性人群的生命健康安全。
研究开发参多糖甜婺金花红茶原料及相关产品，旨在发挥中国传统中医、道家医药经典有效方法，应用现代生命科学和营养学理论，论证传统中医药对女性疾病有效性作用；并为上述女性疾病预防提供一种实用而经济的，具有护理肺、肝、肾、心脑血管作用，能阻碍、预防女性慢性疾病侵蚀，促进人体主肠道、血液免疫营养代谢作用；并适合能、辅助治疗内分泌紊乱、糖尿病、高血脂等方面具有特殊膳食食疗作用的创新产品，以满足上述众多人群的迫切需要，为社会女性人群增加新的产品选择、使用。
发明内容
本发明所要解决的技术问题是提供一种参多糖甜婺金花红茶及其制备方法，旨在克服现有技术中缺乏对上述众多的女性慢性疾病具有阻碍、预防等膳食营养作用且实用而经济的创新产品的不足，提供的参多糖甜婺金花红茶能有效增强人体免疫机能营养，促进人体胃肠道、血液综合代谢，护理肺、肝、肾、心脑血管，预防女性乳腺炎、乳腺肿瘤、糖尿病、高血脂、经期失调、经期失血性贫血、失眠、胃肠道代谢紊乱、便秘、下身宫寒、妇科肿瘤等女性慢性疾病并能康复或辅助治疗内分泌紊乱、糖尿病、高血脂等，是一种具有特殊膳食食疗作用的产品。
本发明解决上述技术问题的技术方案如下：一种参多糖甜婺金花红茶，其由以下重量百分数的各原料组成：人参多糖粉10-40％；葛根膳食纤维素粉5-25％；食用菌多糖粉0.5-5％；淼甜婺金花红茶粉40-70％；脱乙酰基甲壳素粉2-10％；微晶纤维素粉0.5-2.5％。
在上述技术方案的基础上，本发明还可以做如下具体选择。
具体的，淼甜婺金花红茶粉由淼甜婺金花红茶粉碎而成，淼甜婺金花红茶通过以下方法制得：由掌叶覆盆子甜叶、木姜叶柯叶和山茶树茶叶分别先按凉晒、萎凋、杀青、揉捻、固态发酵和低温干燥的发酵茶加工工艺初加工成初发酵毛茶，然后按照1：1：1-3的重量比例充分混合后复合发酵，再汽蒸、紧压、低温发花、低温干燥，即得，低温干燥的温度控制在26-30℃，低温发花的温度控制在16-22℃。
具体的，所述食用菌多糖粉以猴头菇、香菇和杏鲍菇中的一种或多种为原料提取得到。
在上述技术方案的基础上，本发明还提供了制备上述参多糖甜婺金花茶的方法，其包括如下步骤：
步骤A：将淼甜婺金花红茶发花发酵茶原料进行开片、切块、粉碎和过筛，制成淼甜婺金花红茶粉，备用；
步骤B：将人参多糖粉、葛根膳食纤维素粉和食用菌多糖粉按照其重量百分数进行称量并混合，再添加相应量的脱乙酰基甲壳素粉并混合均匀，即得多糖复合粉备用；
步骤C：称取相应重量百分数的步骤A的淼甜婺金花红茶粉并与步骤B得到的相应量的多糖复合粉混合，最后添加相应重量百分数的微晶纤维素粉后，充分混合，搅拌条件下在相对湿度65％，温度22-24℃下，处理3-7天，然后进行干燥，升温至42℃并保持，开启除湿设备，直至相对湿度降低至13％以下，即得所述参多糖甜婺金花红茶原料产品。
本发明提供的参多糖甜婺金花红茶原料产品的终端产品根据需要剂型可生产成粉剂、颗粒剂、冲剂或片剂等多种剂型。
本发明采用的人参多糖粉由人参提取而来，人参多糖是研究较早的多糖类生物活性成分，其生物活性在对免疫功能的调节影响以及由此产生的免疫性抗肿瘤活性等方面则有凸出表现。人参多糖为淡黄色至黄褐色粉末，可溶于热水。具有增强免疫力，促进造血，降血糖，抗利尿，抗衰老，抗血栓，抗菌，抗炎，抗肿瘤等功能。对于女性而言，人参还具有补血补气、调节经期、美容养颜等诸多功效。
本发明在配方中采用葛根膳食纤维素粉是从葛根加工生产中得到的有效营养代谢提取物成分。葛根为豆科葛属植物的块根,是常用的传统中药,是国家卫生健康委公布的药食资源。传统中医证实:葛根性味甘、辛、凉，归肺、胃经；有生津、止渴，解肌退热，透疹、排毒等功效作用，具有清肺热、护理肝功能作用。现代医学证实葛根有效成分具有调节内分泌、抗炎、抗病毒作用，具有增强免疫功能。经中南林业科技大学绿色食品研究所苏勇、李忠海研究员对<<葛根膳食纤维对小白鼠免疫功能的影响>>实验研究证实:葛根膳食纤维可以通过提高胸腺及脾脏指数等提高小白鼠的免疫功能。经赵兰、李忠海研究员对<<葛根膳食纤维(DF)的功能进行评价>>实验研究证实:说明葛根DF可预防糖尿病，治疗由四氧嘧啶所致的糖尿病，改善由四氧嘧啶所致糖尿病小白鼠的糖耐量。膳食纤维素是公认的具有代谢作用的营养素；葛根膳食纤维素是天然的特殊膳食纤维素，具有免疫营养代谢有效调节功能作用。俗话说，“北有人参，南有葛根”。葛根又名粉葛、葛麻藤等，曾被当成贡品进贡宫廷。葛根中富含葛根素、大豆黄酮苷、花生素、蛋白质、氨基酸等营养成分，而且还含有丰富钙、铁、铜、硒等矿物质，不仅具有营养保健的功效，而且药用价值非常突出，是男女老少皆宜的滋补品。早在汉代，张仲景所撰写的《伤寒论》中就有“葛根汤”的方剂，迄今为止，这一方剂仍是重要的解表方。对于女性而言，葛根所富含高活性的异黄酮，能有效调节内分泌，对更年期综合征的失眠、多梦、头晕、目眩、烦躁、不安、猜疑、忧郁等症状表现有很好的调理作用；葛根的异黄酮可以改善毛孔粗大现象，祛除黄褐斑，消退青春痘，让皮肤充满弹性，细腻、滋润，有光泽，葛根中含有大量的膳食纤维，可以有效改善便秘症状，清除体内的毒素，减少肠道疾病的发生。葛根膳食纤维素粉原料，由武汉市紫物源科技有限责任独资开发，2013通过了湖北省食品安全专家评审企业标准备案，企业标准号Q/WZWY0001S—2013，湖北省食品安全备案编号420443S—2013。
本发明采用的食用菌多糖粉，优选提取自猴头菇、香菇和杏鲍菇。在国际上，食用菌多糖被称为称为“生物反应调节物”，简称“BRM”，经研究表明，多糖具有生物反应调节物的特征，可做为免疫增强剂和免疫激活剂，这些活性多糖具有一个的结构，即主链由β－D(1－73)连接的葡萄糖基组成，沿主链随机分布着同β－D(1－73)边接的葡萄糖基呈梳状结构，生物的大小随多糖的精细结构和构象不同而变化。食用菌多糖是一种特殊的生物活性物质，是一种生物反应增强剂和调节剂，它能增强体液免疫和细胞免疫功能。食用菌多糖的抗病毒作用机制可能在于其提高感染细胞免疫力，增强细胞膜的稳定性，抑制细胞病变，促进细胞修复等功能。同时，食用菌多糖还具有抗逆转录病毒活性。因此，食用菌多糖是一种有待开发的抗流感的保健食品。
本发明采用的脱乙酰基甲壳素又称壳聚糖，其为天然多糖甲壳素脱除部分乙酰基的产物，具有生物降解性、生物相容性、无毒性、抑菌、抗癌、降脂、增强免疫等多种生理功能，广泛应用于食品添加剂、纺织、农业、环保、美容保健、化妆品、抗菌剂、医用纤维、医用敷料、人造组织材料、药物缓释材料、基因转导载体、生物医用领域、医用可吸收材料、组织工程载体材料、医疗以及药物开发等众多领域和其他日用化学工业。
本发明采用的微晶纤维素(mcc)系用纯棉纤维经水解制得的粉末，纯含纤维素为97.0％～102.0％。是能自由流动的结晶粉末(非纤维状的微粒子)。不溶于水、稀释的酸和多数的有机溶剂，微溶于20％的碱溶液。在辅料方面用途广泛，可直接用于干粉压片，广泛用作药物赋形剂、流动性助剂、填充物、崩解剂、抗粘剂、吸附剂等。
本发明采用的淼甜婺金花茶由掌叶覆盆子甜叶、木姜叶柯甜叶(简称甜茶)和山茶树茶叶为原料制成，其制备方法为，将掌叶覆盆子甜叶、木姜叶柯甜叶和山茶科茶叶分别发酵毛茶，该加工工艺为现有技术，包括凉晒、萎凋、杀青、揉捻、发酵和低温干燥步骤，其工艺参数可参考现有制茶技术选择；然后将掌叶覆盆子甜叶、木姜叶柯甜叶和山茶科茶叶初加工成的发酵毛茶，然后按照1：1：1-3的重量比例充分混合后复合发酵，再汽蒸、紧压、低温发花和低温干燥，得成品，其为发酵淼甜婺红茶且为砖块状。
关于掌叶覆盆子甜叶茶，覆盆子中药名是中国古代东晋时期道家道医葛洪命名，由古籍书《抱朴子》文献记载所证实。覆盆子是常用的传统中药,属于我国卫生健康委公布的药食资源，2021年2月23日国家卫生健康委行政部门对覆盆子甜叶为食品原料终止审查；传统中医证实:覆盆子性平、无毒、味甘、酸，入肝、肾、膀胱经；具有生津止渴、护肝明目、益肾固精、收敛止泻作用。适用治疗肾虚、尿频遗尿、糖尿病,女性内分泌失调、子宫寒冷、阴湿带下症状。
掌叶覆盆子叶茶经相关科研团队基础研究或相关科研证实:覆盆子甜茶含有甜茶素(rubusoside)、茶多酚、黄酮类化合物甜茶苷等多种生理活性成分,具有抑菌、抗炎、抗过敏功能；具有调节内分泌、降血糖、降血脂,调理人体免疫功能等功效作用。
木姜叶柯的嫩叶有甜味，居民用其叶作茶叶代品，通称甜茶，其作为一种长期被人们广泛使用的别样茶,在2017年通过了国家卫计委的审批可以作为新资源食品使用。中国农业科学院都市农业研究所等权威科研单位的研究表明，甜茶富含二氢查耳酮，主要是根皮苷、三叶苷、根皮素等，甜茶及其二氢查耳酮具有许多健康益处，例如抗氧化、抗炎、抑菌、心脏保护、保肝、抗糖尿病和抗癌作用，这些作用与调节不同的分子靶标和信号传导途径有关。此外，甜茶及其二氢查耳酮成分还展现出了心脏保护、保肝、神经保护和抗肥胖等健康益处。研究表明，甜茶二氢查耳酮可改善心血管疾病的危险因素，如高血压、高血脂、高尿酸、动脉粥样硬化等，且无明显副作用。另外根皮素和根皮苷在不同的化学性肝损伤动物模型中均发挥了积极作用，并可改善肝脏组织病理学病变和肝功能指标。在动物模型中，根皮苷可以缓解神经炎症，改善认知缺陷以及增加记忆存储。此外，根皮苷还有抗肥胖的潜力，可以改善饮食诱导肥胖，其作用机制包括提高棕色脂肪组织的生热作用和降低胰岛素抵抗。
山茶树茶叶是山茶科山茶属植物的叶子制成的茶叶，本发明中优选使用武陵山脉区域、恩施地区富硒地带的制利川红茶的茶树品种。利川红茶叶富含硒；利川红茶色泽乌润，内质清芳并带有蜜糖香味，上品茶更蕴含着兰花香，馥郁持久的特点；茶汤色红艳明亮、滋味鲜醇酣厚、香气清香特久，叶底(泡过的茶渣)红亮。利川红茶具有抗疲劳、清热消暑、利尿、解毒杀菌、稳定血糖等诸多功效。
冠突散囊菌俗称“金花”,属于散囊菌目发菌科散囊菌属的一种真菌,由子囊果和菌丝组成,营养要求低,可在马铃薯葡萄糖琼脂培养基、孟加拉红培养基生长,适应性强,能利用多种氮源、碳源,是茯砖茶发酵过程中的优势菌种,其从茶叶中获取营养物质,通过自身代谢,产生多种酶催化茶叶中各种物质发生转化,形成了茯砖茶特有的色、香、味品质,故其是评价茯砖茶品质的重要指标。茯砖茶真正的“金花”也是“冠突散囊菌”，在存期久远茶品中可能出现。制成的茶品在外冷内热、外干内湿的前提下，茶品内果实较多或鲜叶较粗老而茶叶渗出物浓稠情况下，且得有“冠突散囊菌”存在于茶原料内；或在制成品后摊晾过程遇有此类微生物附着，还得在短期内形成最初的微小群落，才能在以后的储藏过程中逐步生长。
与现有技术相比，本发明的有益效果是：
本发明提供的参多糖甜婺金花红茶原料产品中首次将植物多糖(人参多糖、食用菌多糖等)与动物多糖(壳聚糖)配合，其中动物多糖具有一定的黏膜修复作用并促进植物多糖吸收，能够保证该原料产品中的有效多糖成分更易被人体吸收，从而起到增强免疫、膳食营养的效果。利用掌叶覆盆子、木姜叶柯叶和山茶树叶三元复合发酵，发酵后茶多糖和多酚含量比同等质量的任一种单一组分的发酵茶更高，能够保证生产时金花更快更好的产生，金花茶的品质更高，冠状散囊菌菌落更密，发展更好。多种植物多糖成分与金花茶混合，强化冠状散囊菌的成长条件，促使其再次生长，提升有效成分含量。
本发明的参多糖淼甜婺金花红茶是通过各种有效成份配合，以生津、清热、抗炎、抗敏，调理气血平衡，护理肺、肝、肾、心脑血管等功能，增强人的免疫代谢营养，促进人体胃肠道、血液代谢排毒功能，达到预防、辅助医疗、康复女性慢性疾病的目的。因此，本发明是在历史实践证明传统中医药食药两用茶通过现代生命科学和营养学理论,科学论证传统中医药有效抗炎、抗敏有效成分机理，使参多糖、葛根膳食纤维素、茶多酚、茶多糖、甜茶素等有益有效可测定成分结合成为分子团，使其形成具有免疫营养、促进代谢排毒功能以及防疫、等必然功能作用的新产品。参多糖淼甜婺金花红茶产品可供给人体机体免疫营养、促进能量排毒代谢,改善人体营养平衡，能起到重要特殊膳食的饮食疗作用。
具体实施方式
以下具体实施例对本发明的原理和特征进行描述，所举实例只用于解释本发明，并非用于限定本发明的范围。
以下实施例中用到的淼甜婺金花红茶均由以下方法制备得到：由掌叶覆盆子甜叶、木姜叶柯叶和山茶树茶叶分别先按凉晒、萎凋、杀青、揉捻、固态发酵和低温干燥的发酵茶工艺初加工成毛茶，然后按照1：1：3的重量比例充分混合后，再汽蒸、紧压、低温发花和干燥，即得。其中，掌叶覆盆子叶和木姜叶柯均可使用湖北咸宁地区通山地区采集的产品，山茶树茶叶优选适江华苦茶的叶子。初发酵毛茶制备时萎凋温度在22-26℃，9-12h完成，充分揉捻，保证茶叶细胞组织破坏率达到75％以上，固态发酵时室温控制在27℃左右，空气相对湿度保持在85％以上，发酵时间控制在4h左右，低温干燥的温度控制在26-30℃，干燥至茶叶含水率在5％以下，汽蒸时温度在100-102度左右，时间25s左右，紧压的最大压力在80吨左右，低温发花的温度控制在16-22℃，时间控制在5-8天，烘干后砖片的含水量控制在13％以下。
实施例1
一种参多糖甜婺金花红茶的方法，其包括如下步骤：
步骤A：将淼甜婺金花红茶发花发酵茶原料进行开片、切块、粉碎和过筛，制成淼甜婺金花红茶粉，备用；
步骤B：称量10份人参多糖粉、5份葛根膳食纤维素粉和5份食用菌多糖粉并混合，再添加7.5份脱乙酰基甲壳素粉并混合均匀，即得多糖复合粉备用；
步骤C：称取70份淼甜婺金花红茶粉并与步骤B得到的全部多糖复合粉混合，最后添加2.5份微晶纤维素粉后，充分混合，搅拌条件下在相对湿度65％，温度22℃下，处理7天，然后进行干燥，升温至42℃并保持，开启除湿设备，直至相对湿度降低至13％以下，即得所述参多糖甜婺金花红茶原料产品。
实施例2
一种参多糖甜婺金花红茶的方法，其包括如下步骤：
步骤A：将淼甜婺金花红茶发花发酵茶原料进行开片、切块、粉碎和过筛，制成淼甜婺金花红茶粉，备用；
步骤B：称量15份人参多糖粉、10份葛根膳食纤维素粉和2.5份食用菌多糖粉并混合，再添加10份脱乙酰基甲壳素粉并混合均匀，即得多糖复合粉备用；
步骤C：称取60份淼甜婺金花红茶粉并与步骤B得到的全部多糖复合粉混合，最后添加2.5份微晶纤维素粉后，充分混合，搅拌条件下在相对湿度65％，温度22℃下，处理7天，然后进行干燥，升温至42℃并保持，开启除湿设备，直至相对湿度降低至13％以下，即得所述参多糖甜婺金花红茶原料产品。
实施例3
一种参多糖甜婺金花红茶的方法，其包括如下步骤：
步骤A：将淼甜婺金花红茶发花发酵茶原料进行开片、切块、粉碎和过筛，制成淼甜婺金花红茶粉，备用；
步骤B：称量20份人参多糖粉、15份葛根膳食纤维素粉和2份食用菌多糖粉并混合，再添加6份脱乙酰基甲壳素粉并混合均匀，即得多糖复合粉备用；
步骤C：称取55份淼甜婺金花红茶粉并与步骤B得到的全部多糖复合粉混合，最后添加2份微晶纤维素粉后，充分混合，搅拌条件下在相对湿度65％，温度23℃下，处理5天，然后进行干燥，升温至42℃并保持，开启除湿设备，直至相对湿度降低至13％以下，即得所述参多糖甜婺金花红茶原料产品。
实施例4
一种参多糖甜婺金花红茶的方法，其包括如下步骤：
步骤A：将淼甜婺金花红茶发花发酵茶原料进行开片、切块、粉碎和过筛，制成淼甜婺金花红茶粉，备用；
步骤B：称量25份人参多糖粉、20份葛根膳食纤维素粉和0.5份食用菌多糖粉并混合，再添加2份脱乙酰基甲壳素粉并混合均匀，即得多糖复合粉备用；
步骤C：称取52份淼甜婺金花红茶粉并与步骤B得到的全部多糖复合粉混合，最后添加0.5份微晶纤维素粉后，充分混合，搅拌条件下在相对湿度65％，温度23℃下，处理5天，然后进行干燥，升温至42℃并保持，开启除湿设备，直至相对湿度降低至13％以下，即得所述参多糖甜婺金花红茶原料产品。
实施例5
一种参多糖甜婺金花红茶的方法，其包括如下步骤：
步骤A：将淼甜婺金花红茶发花发酵茶原料进行开片、切块、粉碎和过筛，制成淼甜婺金花红茶粉，备用；
步骤B：称量30份人参多糖粉、25份葛根膳食纤维素粉和1.5份食用菌多糖粉并混合，再添加2份脱乙酰基甲壳素粉并混合均匀，即得多糖复合粉备用；
步骤C：称取40份淼甜婺金花红茶粉并与步骤B得到的全部多糖复合粉混合，最后添加1.5份微晶纤维素粉后，充分混合，搅拌条件下在相对湿度65％，温度23℃下，处理5天，然后进行干燥，升温至42℃并保持，开启除湿设备，直至相对湿度降低至13％以下，即得所述参多糖甜婺金花红茶原料产品。
实施例6
一种参多糖甜婺金花红茶的方法，其包括如下步骤：
步骤A：将淼甜婺金花红茶发花发酵茶原料进行开片、切块、粉碎和过筛，制成淼甜婺金花红茶粉，备用；
步骤B：称量35份人参多糖粉、5份葛根膳食纤维素粉和5份食用菌多糖粉并混合，再添加4份脱乙酰基甲壳素粉并混合均匀，即得多糖复合粉备用；
步骤C：称取50份淼甜婺金花红茶粉并与步骤B得到的全部多糖复合粉混合，最后添加1份微晶纤维素粉后，充分混合，搅拌条件下在相对湿度65％，温度24℃下，处理3天，然后进行干燥，升温至42℃并保持，开启除湿设备，直至相对湿度降低至13％以下，即得所述参多糖甜婺金花红茶原料产品。
实施例7
一种参多糖甜婺金花红茶的方法，其包括如下步骤：
步骤A：将淼甜婺金花红茶发花发酵茶原料进行开片、切块、粉碎和过筛，制成淼甜婺金花红茶粉，备用；
步骤B：称量40份人参多糖粉、10份葛根膳食纤维素粉和5份食用菌多糖粉并混合，再添加2.5份脱乙酰基甲壳素粉并混合均匀，即得多糖复合粉备用；
步骤C：称取40份淼甜婺金花红茶粉并与步骤B得到的全部多糖复合粉混合，最后添加2.5份微晶纤维素粉后，充分混合，搅拌条件下在相对湿度65％，温度24℃下，处理3天，然后进行干燥，升温至42℃并保持，开启除湿设备，直至相对湿度降低至13％以下，即得所述参多糖甜婺金花红茶原料产品。
实施例8
一种参多糖甜婺金花红茶的方法，其包括如下步骤：
步骤A：将淼甜婺金花红茶发花发酵茶原料进行开片、切块、粉碎和过筛，制成淼甜婺金花红茶粉，备用；
步骤B：称量20份人参多糖粉、25份葛根膳食纤维素粉和0.5份食用菌多糖粉并混合，再添加2份脱乙酰基甲壳素粉并混合均匀，即得多糖复合粉备用；
步骤C：称取50份淼甜婺金花红茶粉并与步骤B得到的全部多糖复合粉混合，最后添加2.5份微晶纤维素粉后，充分混合，搅拌条件下在相对湿度65％，温度24℃下，处理3天，然后进行干燥，升温至42℃并保持，开启除湿设备，直至相对湿度降低至13％以下，即得所述参多糖甜婺金花红茶原料产品。
需要说明的是，以上各实施例对应的原料产品，按所需剂型，选用对应的成型设备，可生产成粉剂、颗粒剂、冲剂或片剂四种剂型。
以上所述仅为本发明的较佳实施例，并不用以限制本发明，凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (4)
1.一种参多糖甜婺金花红茶，其特征在于，由以下重量百分数的各原料组成：人参多糖粉10-40％；葛根膳食纤维素粉5-25％；食用菌多糖粉0.5-5％；淼甜婺金花红茶粉40-70％；脱乙酰基甲壳素粉2-10％；微晶纤维素粉0.5-2.5％。
2.根据权利要求1所述的一种参多糖甜婺金花红茶，其特征在于，淼甜婺金花红茶粉由淼甜婺金花红茶粉碎而成，淼甜婺金花红茶通过以下方法制得：由掌叶覆盆子甜叶、木姜叶柯叶和山茶科茶树茶叶分别先按凉晒、萎凋、杀青、揉捻、固态发酵和低温干燥的发酵茶加工工艺初加工成初发酵毛茶，然后按照1：1：1-3的重量比例充分混合后复合发酵，再汽蒸、紧压、低温发花、低温干燥，即得，低温干燥的温度控制在26-30℃，低温发花的温度控制在16-22℃。
3.根据权利要求1所述的一种参多糖甜婺金花红茶，其特征在于，所述食用菌多糖粉以猴头菇、香菇和杏鲍菇中的一种或多种为原料提取得到。
4.一种权利要求1或2所述参多糖甜婺金花红茶的制备方法，其特征在于，包括如下步骤：
步骤A：将淼甜婺金花红茶发花发酵茶原料进行开片、切块、粉碎和过筛，制成淼甜婺金花红茶粉，备用；
步骤B：将人参多糖粉、葛根膳食纤维素粉和食用菌多糖粉按照其重量百分数进行称量并混合，再添加相应量的脱乙酰基甲壳素粉并混合均匀，得多糖复合粉备用；
步骤C：称取相应重量百分数的步骤A的淼甜婺金花红茶粉并与步骤B得到的多糖复合粉混合，最后添加相应重量百分数的微晶纤维素粉后，充分混合，搅拌条件下在相对湿度65％、温度22-24℃下，处理3-7天，然后升温至42℃并保持，开启除湿设备进行干燥，直至相对湿度降低至13％以下，即得所述参多糖甜婺金花红茶原料产品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210131791.6A CN114568557B (zh) | 2022-02-14 | 2022-02-14 | 一种参多糖甜婺金花红茶及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210131791.6A CN114568557B (zh) | 2022-02-14 | 2022-02-14 | 一种参多糖甜婺金花红茶及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114568557A true CN114568557A (zh) | 2022-06-03 |
| CN114568557B CN114568557B (zh) | 2024-01-26 |
Family
ID=81773596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210131791.6A Active CN114568557B (zh) | 2022-02-14 | 2022-02-14 | 一种参多糖甜婺金花红茶及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114568557B (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010066713A (ko) * | 1999-12-31 | 2001-07-11 | 박명규 | 다이어트 인삼제품 제조방법 |
| WO2018058851A1 (zh) * | 2016-09-28 | 2018-04-05 | 湖南华诚生物资源股份有限公司 | 一种罗汉果益生元菊花茶速溶饮品及其制备方法 |
| CN108024958A (zh) * | 2015-09-24 | 2018-05-11 | 金善实 | 生物纳米金多糖胶体溶液及其制造方法 |
| CN109380729A (zh) * | 2018-12-12 | 2019-02-26 | 杞源堂(天津)生物工程有限公司 | 一种补气养血的枸杞胶囊及其制备方法 |
| CN112515014A (zh) * | 2020-12-03 | 2021-03-19 | 紫物境界(十堰市武当山旅游经济特区)农业科技有限公司 | 一种葛根多糖甜宗红茶及其制备方法 |
| CN112741178A (zh) * | 2021-01-19 | 2021-05-04 | 武汉市紫物源科技有限责任公司 | 一种荷叶多糖甜茯茶及其制备方法 |
-
2022
- 2022-02-14 CN CN202210131791.6A patent/CN114568557B/zh active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010066713A (ko) * | 1999-12-31 | 2001-07-11 | 박명규 | 다이어트 인삼제품 제조방법 |
| CN108024958A (zh) * | 2015-09-24 | 2018-05-11 | 金善实 | 生物纳米金多糖胶体溶液及其制造方法 |
| WO2018058851A1 (zh) * | 2016-09-28 | 2018-04-05 | 湖南华诚生物资源股份有限公司 | 一种罗汉果益生元菊花茶速溶饮品及其制备方法 |
| CN109380729A (zh) * | 2018-12-12 | 2019-02-26 | 杞源堂(天津)生物工程有限公司 | 一种补气养血的枸杞胶囊及其制备方法 |
| CN112515014A (zh) * | 2020-12-03 | 2021-03-19 | 紫物境界(十堰市武当山旅游经济特区)农业科技有限公司 | 一种葛根多糖甜宗红茶及其制备方法 |
| CN112741178A (zh) * | 2021-01-19 | 2021-05-04 | 武汉市紫物源科技有限责任公司 | 一种荷叶多糖甜茯茶及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114568557B (zh) | 2024-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
| CN102940155B (zh) | 一种樱桃谷鸭的雏鸭饲料及其制备方法 | |
| CN111374297A (zh) | 一种复合食盐及其制备方法 | |
| CN101612315A (zh) | 一种用于调整人体机能的中药复方制剂 | |
| CN103168883A (zh) | 可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂及其制备方法 | |
| CN107714794B (zh) | 俄色提取物片剂及其制备方法 | |
| CN105384562A (zh) | 一种袖珍菇培养基 | |
| KR101826737B1 (ko) | 생약재 추출물을 유효성분으로 하는 근육틱 및 우울증 개선용 조성물 및 그의 제조방법 | |
| JP2016077283A (ja) | 農産物と穀物菌糸体とが混合され、発酵された抗癌、抗糖尿、免疫増進用の発酵禅食組成物及びその製造方法｛Ｆｅｒｍｅｎｔｅｄｆｏｏｄｃｏｍｐｏｓｉｔｉｏｎｃｏｍｐｒｉｓｉｎｇａｇｒｉｃｕｌｔｕｒａｌｐｒｏｄｕｃｔｓａｎｄｍｙｃｅｌｉｕｍｍｉｘｔｕｒｅｆｏｒｐｒｅｖｅｎｔｉｎｇｏｒｔｒａｔｉｎｇｃａｎｃｅｒ、ｄｉａｂｅｔｉｃｓａｎｄｉｍｐｒｏｖｉｎｇｉｍｍｕｎｅｆｕｎｃｔｉｏｎ、ａｎｄｐｒｅｐａｒａｔｉｏｎｍｅｔｈｏｄｔｈｅｒｅｏｆ｝ | |
| CN106362125A (zh) | 一种保健足贴及其使用方法 | |
| CN105664140A (zh) | 一种糖肽组合物及其制备方法和用途 | |
| CN106421208B (zh) | 一种具有抗化学性肝损伤功能的药物组合物及其制备方法 | |
| CN112515014A (zh) | 一种葛根多糖甜宗红茶及其制备方法 | |
| CN112741178A (zh) | 一种荷叶多糖甜茯茶及其制备方法 | |
| CN104489172A (zh) | 一种提高免疫力的刺五加保健茶及其制备方法 | |
| CN104940241B (zh) | 一种防治妇女更年期综合征的硒虫草复方制剂 | |
| CN111387345A (zh) | 一种复合多糖组合物及其制备方法 | |
| CN114568557B (zh) | 一种参多糖甜婺金花红茶及其制备方法 | |
| KR20100102890A (ko) | 약용식물 추출액을 이용한 기능성 음료 제조방법 | |
| KR101028073B1 (ko) | 혈액순환을 개선하여 신체 각 부위를 활성화 시키며 면역력을 증진시키는 작용 및 기전을 가진 조성물과 그 제조방법 | |
| CN108208267A (zh) | 一种降血压、降血脂、降血糖和减肥塑形作用的袋泡酵素养生茶 | |
| CN113040177A (zh) | 一种降解农作物农药残留的植物发酵提取物及其制备方法 | |
| KR101093006B1 (ko) | 미생물을 이용한 우황 청심원 원료 함유 건강식품의 제조방법 및 그 제조방법에 의해 제조된 건강식품 | |
| CN112076305A (zh) | 一种治疗人体代谢症候群及杀菌消炎的中药制内服外用原液合剂 | |
| CN109620858A (zh) | 防治糖尿病的药食同源制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |